These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2543310)

  • 1. Evaluation of management of gestational trophoblastic tumor in National Taiwan University Hospital.
    Ouyang PC
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1544-52. PubMed ID: 2543310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
    Laan R; Bakker P; Lammes FB
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of high-risk trophoblastic neoplasia].
    Kawashima Y; Maeda M; Sugimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2658-66. PubMed ID: 2820310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
    Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
    Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metastases in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):107-11. PubMed ID: 2999663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of high-risk gestational trophoblastic disease.
    Surwit EA
    J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
    Bircher C; Smith RP; Seckl MJ; Brown D; Short D; Rees H; McCarthy A; Nirmal DM
    BJOG; 2011 Dec; 118(13):1672-5. PubMed ID: 21790953
    [No Abstract]   [Full Text] [Related]  

  • 15. Poor-prognosis gestational trophoblastic disease: an update.
    Surwit EA; Alberts DS; Christian CD; Graham VE
    Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
    Ayhan A; Yapar EG; Deren O; Kişnişçi H
    J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.